A brief mental health and substance abuse screener for persons with HIV.

Published

Journal Article

Mental illness and substance abuse are common among HIV-infected individuals and are associated with negative outcomes, including poor medication adherence. Therefore, quick and effective methods for detecting these co-occurring disorders are necessary for health care practitioners. This article reports on the creation and preliminary testing of a brief screening tool, the Substance Abuse and Mental Illness Symptoms Screener (SAMISS). The 13-item screener was developed primarily from existing scales and administered to HIV-infected individuals receiving care at infectious diseases clinics in the Southeast. To assess the validity of the SAMISS, a subset of those who screened positive for both mental illness symptoms and substance use problems (n = 207) were administered the Structured Clinical Interview for DSMIV Disorders (SCID). The positive predictive value of the screener in comparison to the SCID was 98.6% for mental disorders and 98.6% for substance use disorders. The agreement between specific screener symptoms and their corresponding SCID diagnoses was relatively high for alcohol dependence (kappa = 0.50, p < 0.001), drug dependence (kappa = 0.30, p < 0.001), and drug abuse (kappa = 0.42, p <0.001). The finding that the screener is highly predictive of having a general mental disorder and substance use disorder among those screening positive for mental illness symptoms and substance use problems, as well as its brevity and ease of administration, make it a useful tool to detect symptoms of co-occurring disorders so that patients can be referred to mental health and substance abuse specialists. The screener is not a diagnostic instrument and has limited value in predicting specific psychiatric diagnoses.

Full Text

Duke Authors

Cited Authors

  • Whetten, K; Reif, S; Swartz, M; Stevens, R; Ostermann, J; Hanisch, L; Eron, JJ

Published Date

  • February 2005

Published In

Volume / Issue

  • 19 / 2

Start / End Page

  • 89 - 99

PubMed ID

  • 15716640

Pubmed Central ID

  • 15716640

International Standard Serial Number (ISSN)

  • 1087-2914

Digital Object Identifier (DOI)

  • 10.1089/apc.2005.19.89

Language

  • eng

Conference Location

  • United States